<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260605069646N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-10</date_registration>
      <primary_sponsor>Razi Univeristy</primary_sponsor>
      <public_title>Effect of Six‑Week Corrective Exercise and Collagen‑Vitamin C Supplementation on Pain, Function, and Quality of Life in Female Athletes with Achilles Tendinopathy</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of Six Weeks of Corrective Exercises Combined with Hydrolyzed Collagen and Vitamin C Supplementation on Pain, Function, and Quality of Life in Female Athletes Players with Achilles Tendinopathy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/90676</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization is performed using block randomization with block sizes of 4 (or 6). The allocation sequence is generated by statistical software or a random number table and placed in sequentially numbered, opaque, sealed envelopes. Group allocation is carried out by an independent individual (not involved in assessment or intervention delivery) to ensure allocation concealment. The outcome assessor and participants remain blinded to group assignment (assessor‑blinded design), Blinding description: Blinding is applied only to participants. Both groups receive the same corrective exercise program, but participants are unaware of which supplement they are taking. The active supplement (collagen + vitamin C) and placebo are completely identical in appearance, odor, taste, color, size, and packaging, and are coded by an individual independent of the research team. Thus, participants do not know whether they are in the supplement or placebo group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Female Athletes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention group (n=15) consumes 30 g of hydrolyzed collagen plus 500 mg of vitamin C one hour before each corrective exercise session, performed three times per week for six weeks. Intervention 2: Control group: The control group (n=15) consumes a placebo (maltodextrin plus 500 mg of vitamin C) one hour before each corrective exercise session, performed three times per week for six weeks, following the same exercise protocol as the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be recorded in the SPSS software and will be available

When:
Availability will start nine months after publishing all papers

To whom:
Only available for researchers in academic and scientific institutions

Conditions:
All data can be used as a reference

Where to obtain:
asalbesanj@gmail.com

How to obtain:
All data can be used as a reference

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hidar Menochari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 9, Razi University, Daneshgah Boulevard, Taq Bostan Street, Kermanshah City</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714967346</zip>
        <telephone>+98 83 3428 3270</telephone>
        <email>mhaidary2000@yahoo.com</email>
        <affiliation>Razi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Menocher Hidary</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 9, Razi University, Daneshgah Boulevard, Taq Bostan Street, Kermanshah City</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714967346</zip>
        <telephone>+98 83 3428 3270</telephone>
        <email>mhaidary2000@yahoo.com</email>
        <affiliation>Razi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Clinical diagnosis of mid‑portion Achilles tendinopathy (pain and tenderness ۲–۶ cm above insertion) confirmed by a specialist or imaging (ultrasound/MRI).
Recreational to semi‑professional female athletes with at least ۳ exercise sessions per week, aged ۱۸–۴۵ years.
Pain intensity ≥ ۳/۱۰ on Visual Analogue Scale (VAS) during daily or sports activity for at least the past ۴ weeks.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>28 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of Achilles surgery, complete rupture, corticosteroid or PRP injection in the last ۶ months
Systemic diseases affecting tissue repair (uncontrolled diabetes, rheumatoid arthritis, renal failure) or allergy to collagen/vitamin C.
Pregnancy, lactation, regular use of analgesics/NSAIDs in the ۲ weeks prior to the study, or concurrent participation in other targeted physiotherapy/exercise interventions for Achilles.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention group (n=15) consumes 30 g of hydrolyzed collagen plus 500 mg of vitamin C one hour before each corrective exercise session, performed three times per week for six weeks.</i_keyword>
      <i_keyword>Control group: The control group (n=15) consumes a placebo (maltodextrin plus 500 mg of vitamin C) one hour before each corrective exercise session, performed three times per week for six weeks, following the same exercise protocol as the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Measurement time points are two: baseline (week 0) and post‑test (week 6). Method of measurement: pain via Visual Analogue Scale (VAS, 0‑10) during sports activity.</prim_outcome>
      <prim_outcome>Achilles‑specific function. Timepoint: Measurement time points are two: baseline (week 0) and post‑test (week 6). Method of measurement: function via the VISA‑A questionnaire (8 items, 0‑100).</prim_outcome>
      <prim_outcome>Quality of life/daily functional. Timepoint: Measurement time points are two: baseline (week 0) and post‑test (week 6). Method of measurement: Quality of life/daily function via the Lower Extremity Functional Scale (LEFS, 20 items, 0‑80).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Razi Univeristy</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-12</approval_date>
        <contact_name>Ethics Committee of Razi University of Kermanshah</contact_name>
        <contact_address>No. 8, Razi University, Daneshgah Boulevard, Taq Bostan Street, Kermanshah, Iran Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
